Dr Jessica Ferguson
Research Assistant
School of Health Sciences
- Email:jessica.ferguson@newcastle.edu.au
- Phone:(02) 4921 5636
Career Summary
Biography
Dr Jessica Ferguson is a Postdoctoral Research Fellow at the Nutraceuticals Research Program at the University of Newcastle. She graduated with a Bachelor of Nutrition and Dietetics (Honours Class 1) in 2014 and is now an Accredited Practising Dietitian & Accredited Nutritionist. Jessica obtained her PhD from The University of Newcastle in July 2019 through which she explored the cardiovascular health benefits of food bioactives in individuals with high cholesterol, focusing particular attention on phytosterols, curcumin and oat beta-glucan. Since completion of her PhD, Jessica has continued her research in the area of nutrition and chronic disease prevention and has expanded her research program to the exploration of plant-based dietary patterns in Australian adults. Alongside her research endeavors, Dr Ferguson also works as a private practice Dietitian consulting patients across a diverse range of health conditions where she provides up-to-date evidence based nutrition counselling utilizing a patient-centered tailored approach to achieve clinical outcomes.
Jessica has published peer-reviewed manuscripts in prestigious journals such as Prog Lipid Res (IF 16.2), Nutr Rev (IF 7.1), Metab Clin & Exp (IF 8.7) and Clin Nutr (6.8). She has also published one book chapter and delivered several conference abstracts both nationally and internationally. Thus far, Dr Ferguson's work has been recognized by the receipt of over 20 grants, awards and scholarships spreading across national and international bodies as well as industry. Her recent research on curcumin and phytosterols for cholesterol management was recognized by the 2018 Junior Investigator Award by the Journal 'Metabolism - Clinical & Experimental' and the Top New Investigator Award by the International Society For the Study of Fatty Acids and Lipids (ISSFAL) in 2018.
Dr Ferguson is the current Chair (2020-current) of the Newcastle Branch of the Nutrition Society of Australia (NSA) as well as National NSA Committee Member and has served as a local committee member since 2017.
Research Expertise
Dr Ferguson has expertise in conceptualizing, designing, coordinating and conducting all aspects of human randomised controlled trials. To date, Dr Ferguson has successfully led clinical trials that focus on lowering or preventing cardio-metabolic risk factors in free-living individuals from the community via dietary changes including incorporation of bioactives. Another aspect of Jessica's research program includes secondary analyses of large population-based cohort studies where she is examining the nutritional adequacy of specific dietary patterns and their link with chronic disease. The translational capacity of her research has led to regular media engagement, including coverage on Australian television and several radio interviews, newspaper and web-based media sites. Jessica is passionate about equipping individuals with the self-efficacy to manage their cardio-metabolic disease risk factors and optimize overall health for sustainable and effective cardio-protection in the long-term.
Teaching Expertise
Jessica's teaching experience lies in clinical nutrition, food science and biochemical aspects of human health and disease and spreads across disciplines of Nutrition & Dietetics, Biomedical Science and Pharmacy. She has taught across a diverse range of areas for example: biochemical aspects of nutrition-related diseases; chronic disease management; glycaemic, cholesterol and lipid metabolism; inflammatory markers and antioxidants; dietetic assessment and intervention; identifying, preventing and treating nutritional deficiencies; gastrointestinal health; food science and labelling policies; dietary supplements and clinical research design. Dr Ferguson has covered these topic areas as a lecturer to undergraduate students in Clinical Research Design (HUBS2408), Gastrointestinal Health and Solid Dosage Formulations (PHAR2203) and postgraduate students for Masters of Pharmacy (PHAR6231) as well as tutor and managed labs for HUBS3280 (Nutritional Biochemistry), NUDI3220 (Clinical Nutrition) and Food Science 2 (NUDI2220). Jessica's teaching expertise has also involved course development and marking.
Dr Ferguson is currently co-supervising one PhD student and 1 Honours student and has supervised 2 Honours students to completion from Nutrition & Dietetics.
Qualifications
- Doctor of Philosophy in Nutritional Biochemistry, University of Newcastle
- Bachelor of Nutrition and Dietetics (Honours), University of Newcastle
Keywords
- Cardiometabolic disease risk management
- Complementary Medicine
- Diet
- Dietary Fats and Oils
- Dietetics
- Functional Foods
- Lipids
- Nutraceuticals
- Nutrition
- Nutritional Biochemistry
Fields of Research
Code | Description | Percentage |
---|---|---|
321004 | Nutritional science | 34 |
320599 | Medical biochemistry and metabolomics not elsewhere classified | 33 |
320101 | Cardiology (incl. cardiovascular diseases) | 33 |
Professional Experience
Professional appointment
Dates | Title | Organisation / Department |
---|---|---|
1/3/2015 - | Accredited Practising Dietitian / Accredited Nutritionist (Private Practice) | Feast For Health Australia |
Teaching appointment
Dates | Title | Organisation / Department |
---|---|---|
27/7/2015 - 27/11/2020 |
Casual Academic Casual lecturer, tutor, curriculum development and marking |
The University of Newcastle School of Biomedical Sciences & Pharmacy Australia |
Awards
Award
Year | Award |
---|---|
2018 |
ISSFAL Top New Investigator Award International Society For the Study of Fatty Acids and Lipids (ISSFAL) |
2018 |
2018 Metabolism Award for Junior Investigators Metabolism - Clinical & Experimental |
2018 |
2018 Innovation Award Priority Research Centre for Physical Activity and Nutrition - The University of Newcastle |
2017 |
Dietitians Association of Australia Healthcare Professional Program Travel Grant 2017 Dietitians Association of Australia |
Nomination
Year | Award |
---|---|
2017 |
Competitively nominated as runner-up by the University of Newcastle to attend the Australian Academy of Science 68th Lindau Nobel Laureate Meeting - Germany University of Newcastle |
Research Award
Year | Award |
---|---|
2018 |
ISSFAL New Investigator Award International Society For the Study of Fatty Acids and Lipids (ISSFAL) |
2018 |
ISSFAL Travel Award AlaskOmega |
2018 |
Best Paper Award in the theme of Clinical Experimental Nutrition for 2015, 2016 and 2018 Priority Research Centre for Physical Activity and Nutrition, University of Newcastle |
2018 |
Best oral presentation for abstract titled ‘Oat β-Glucan Enhances the Lipid-Lowering Effects of Phytosterols in Individuals with Hypercholesterolaemia.’ Nutrition Society of Australia (Newcastle Branch) |
2014 |
Best Poster Presentation for abstract titled ‘Association between omega-3 PUFA and blood lipid profile in older Australians.’ Nutrition Society of Australia (Newcastle Branch) |
Scholarship
Year | Award |
---|---|
2017 |
Hunter Medical Research Institute Greaves Family Postgraduate Top-Up Scholarship Hunter Medical Research Institute (HMRI) |
2016 |
Hunter Medical Research Institute Future Medical Research Scholarship Hunter Medical Research Institute (HMRI) |
Teaching
Code | Course | Role | Duration |
---|---|---|---|
NUDI3220 |
Clinical Nutrition 1 School of Health Science, Faculty of Health & Medicine, The University of Newcastle |
Casual Tutor, Casual Lab Teacher | 25/2/2019 - 28/6/2019 |
HUBS2408 |
Clinical Research Design School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle |
Casual Lecturer, Tutor, Curriculum development | 29/7/2019 - 27/11/2020 |
PHA6231 |
Masters of Pharmacy School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle Developed and delivered Nutraceutical Module for the Masters of Pharmacy Program |
Casual Tutor, Curriculum development | 27/7/2015 - 25/11/2016 |
HUBS3280 |
Nutritional Biochemistry School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle |
Casual Tutor, Curriculum development | 4/8/2015 - 11/11/2020 |
NUDI2220 |
Food Science 2 School of Health Sciences, Faculty of Health and Medicine, University of Newcastle |
Casual Lab Teacher | 25/2/2019 - 28/6/2019 |
PHAR2203 |
Gastrointestinal Health and Solid Dosage Formulations School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle |
Casual Lecturer, Tutor, Curriculum development | 8/8/2016 - 30/11/2018 |
Publications
For publications that are currently unpublished or in-press, details are shown in italics.
Chapter (1 outputs)
Year | Citation | Altmetrics | Link | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2016 |
Ferguson JJA, Dias CB, Garg ML, 'Omega-3 polyunsaturated fatty acids and hyperlipidaemias', Omega-3 Fatty Acids: Keys to Nutritional Health 67-78 (2016) [B1] Hyperlipidaemia is a multifaceted risk factor for cardiovascular disease, involving multiple aetiologies such as diet, lifestyle, and/or metabolic effects within the body. Dietary... [more] Hyperlipidaemia is a multifaceted risk factor for cardiovascular disease, involving multiple aetiologies such as diet, lifestyle, and/or metabolic effects within the body. Dietary long-chain omega-3 polyunsaturated fatty acids (n-3PUFA) have been shown to regulate key pathways involved in lipid metabolism. By this action, n-3PUFA favourably modulate blood lipids such as triglycerides (TG), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). The hypolipidaemic effects of dietary supplementation with n-3PUFA may be enhanced by combination drug or natural therapies and have the potential to reduce dependence on lipid-lowering drug therapy. The widespread modulatory effects on blood lipid profile are not only dose dependent, but also dependent on genetic make-up and gender differences. Further investigation into the modulatory effects of dietary n-3PUFA on blood lipids is warranted in order to optimize the efficacy of n-3PUFA therapy for the prevention and management of hyperlipidaemias. Future studies should investigate the influence of gender and genotypic variants on the effects of dietary n-3PUFA in order to optimize dietary strategies and recommendations to prevent and manage hyperlipidaemias.
|
Nova |
Journal article (19 outputs)
Year | Citation | Altmetrics | Link | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2023 |
Clarke ED, Ferguson JJA, Stanford J, Collins CE, 'Dietary Assessment and Metabolomic Methodologies in Human Feeding Studies: A Scoping Review', Advances in Nutrition, 14 1453-1465 (2023) [C1]
|
Nova | |||||||||
2023 |
Ferguson JJA, Clarke E, Stanford J, Burrows T, Wood L, Collins C, 'Dietary metabolome profiles of a Healthy Australian Diet and a Typical Australian Diet: protocol for a randomised cross-over feeding study in Australian adults', BMJ OPEN, 13 (2023)
|
||||||||||
2023 |
Clarke ED, Stanford J, Ferguson JJA, Wood LG, Collins CE, 'Red Blood Cell Membrane Fatty Acid Composition, Dietary Fatty Acid Intake and Diet Quality as Predictors of Inflammation in a Group of Australian Adults.', Nutrients, 15 (2023) [C1]
|
Nova | |||||||||
2022 |
Thota RN, Chatterjee P, Pedrini S, Hone E, Ferguson JJA, Garg ML, Martins RN, 'Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults', Frontiers in Endocrinology, 13 [C1]
|
Nova | |||||||||
2022 |
Ferguson JJ, Oldmeadow C, Mishra GD, Garg ML, 'Plant-based dietary patterns are associated with lower body weight, BMI and waist circumference in older Australian women.', Public Health Nutr, 25 18-31 (2022) [C1]
|
Nova | |||||||||
2022 |
Ferguson JJA, Oldmeadow C, Bentley D, Eslick S, Garg ML, 'Effect of a polyphenol-rich dietary supplement containing Pinus massoniana bark extract on blood pressure in healthy adults: A parallel, randomized placebo-controlled trial', Complementary Therapies in Medicine, 71 (2022) [C1] Objectives: High blood pressure (BP) is a major risk factor for cardiovascular disease and prevalence rates continue to rise with ageing populations. Polypharmacy remains a burden... [more] Objectives: High blood pressure (BP) is a major risk factor for cardiovascular disease and prevalence rates continue to rise with ageing populations. Polypharmacy remains a burden among the ageing, thus alternative effective strategies are warranted. This study investigated the effects of a polyphenols rich dietary supplement containing Pinus massoniana bark extract (PMBE) for modulating BP in healthy Australian adults. Design: This study is a secondary analysis of data from a double-blinded, placebo-controlled clinical trial. Methods: Sixty-two healthy adults aged 55¿75 years were randomized to receive 50 mL dietary supplement containing placebo (0 mg PMBE) or PMBE (1322 mg PMBE) daily for 12 weeks. Seated systolic BP (SBP) and diastolic (DBP) were measured at baseline, 6 weeks and 12 weeks. Effects of PMBE on modulating BP was also explored in this study stratified for SBP status (optimal v high) as well as by SBP medication status. Mixed effect regression modelling was employed involving fixed categorical effects for elapsed time, treatment assignment and their interaction as well as random subject-level intercept to account for within-subject correlations resulting from repeated measurements. Significant models were further examined by addition of covariates and power calculations were performed since this study was a secondary analysis. Results: SBP significantly reduced (-3.29 mmHg, p = 0.028) after PMBE at 12 weeks compared to baseline. SBP in individuals with normal-high SBP (>120 mmHg) in the PMBE group reduced by - 6.46 mmHg (p = 0.001) at 12 weeks compared to baseline. No significant changes were reported for individuals with optimal (=120 mmHg) SBP nor did DBP significantly change in either study groups. In individuals with non-medicated normal-high SBP, SBP significantly reduced by - 7.49 mmHg (p = 0.001) and DBP by - 3.06 mmHg (p = 0.011) at 12 weeks compared to baseline after PMBE. Cross-group comparisons were not statistically different. Conclusions: A polyphenol-rich dietary supplement derived from PMBE led to a clinically and statistically significant reduction in SBP in adults. Future studies to investigate the effects of PMBE-polyphenol supplementation on BP are warranted to confirm and explore optimal dose and impact on hypertension.
|
Nova | |||||||||
2022 |
Baleato CL, Ferguson JJA, Oldmeadow C, Mishra GD, Garg ML, 'Plant-Based Dietary Patterns versus Meat Consumption and Prevalence of Impaired Glucose Intolerance and Diabetes Mellitus: A Cross-Sectional Study in Australian Women', Nutrients, 14 4152-4152 [C1]
|
Nova | |||||||||
2022 |
Ferguson JJA, Oldmeadow C, Bentley D, Garg ML, 'Antioxidant Effects of a Polyphenol-Rich Dietary Supplement Incorporating Pinus massoniana Bark Extract in Healthy Older Adults: A Two-Arm, Parallel Group, Randomized Placebo-Controlled Trial', Antioxidants, 11 (2022) [C1]
|
Nova | |||||||||
2021 |
Ferguson JJA, Abbott KA, Garg ML, 'Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials', NUTRITION REVIEWS, 79 1043-1066 (2021) [C1]
|
Nova | |||||||||
2021 |
Austin G, Ferguson JJ, Thota RN, Singh H, Burrows T, Garg ML, 'Postprandial lipaemia following consumption of a meal enriched with medium chain saturated and/or long chain omega-3 polyunsaturated fatty acids. A randomised cross-over study', Clinical Nutrition, 40 420-427 (2021) [C1] Background & aims: Postprandial lipaemic response has emerged as a risk factor for cardiovascular disease. Dietary fats such as medium-chain saturated fatty acids (MCSFA) and ... [more] Background & aims: Postprandial lipaemic response has emerged as a risk factor for cardiovascular disease. Dietary fats such as medium-chain saturated fatty acids (MCSFA) and long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) are known to reduce postprandial lipaemic responses. The combination of the two could potentially have complementary and/or synergistic effects for optimising cardiovascular health. This study aims to investigate the effects of MCSFA (coconut oil) with or without LCn-3PUFA (fish oil) inclusion in the test meal on postprandial blood lipids in healthy adults. Methods: In a randomised, double-blinded, placebo-controlled, 2 × 2 factorial cross-over study, participants (n = 15) were randomised to receive four standardised isocaloric test meals. Test meals include: placebo [PL, containing no fish oil (0 g EPA & DHA) or coconut oil (0 g MCSFA)], fish oil [FO, 6 g fish oil (3.85 g EPA & DHA), containing no coconut oil (0 g MCSFA)], coconut oil [CO, 18.65 g coconut oil (15 g MCSFA), containing no fish oil (0 g EPA & DHA)] and coconut oil + fish oil [COFO, 18.65 g coconut oil (15 g MCSFA) + 6 g fish oil (3.85 g EPA & DHA)]; all providing a total fat content of 33.5 g. Participants received all four treatments on four separate test days with at least 3 days washout in between. Blood parameters were measured by finger pricks at 7 timepoints between 0 and 300min. The primary outcome of this study was the change in postprandial triglycerides (TG) concentrations with secondary outcomes as total cholesterol, high-density lipoprotein cholesterol and blood glucose concentrations. Results: TG area under the curve (AUC) (mmol/L/min) was significantly lower for FO (383.67, p = 0.0125) and COFO (299.12, p = 0.0186) in comparison to PL (409.17) only. TG incremental area under the curve (iAUC) (mmol/L/min) was significantly lower with COFO (59.67) in comparison to CO (99.86), (p = 0.0480). Compared to PL, the change in absolute TG concentrations (mmol/L) from baseline to post TG peak time (180min) after FO were significantly less at 240min (0.39 vs 0.15), 270min (0.2 vs 0.1), and 300min (0.28 vs 0.06), and after COFO was significantly less at 300min (0.28 vs 0.16) (p < 0.05). No significant differences in postprandial AUC and iAUC for any other blood parameters were reported. Conclusions: Our study demonstrated that LCn-3PUFA with or without MCSFA but not MCSFA alone are effective in reducing postprandial TG in healthy individuals.
|
Nova | |||||||||
2021 |
Austin G, Ferguson JJA, Garg ML, 'Effects of Plant-Based Diets on Weight Status in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials', NUTRIENTS, 13 (2021) [C1]
|
Nova | |||||||||
2020 |
Ferguson JJ, Stojanovski E, MacDonald-Wicks L, Garg ML, 'High molecular weight oat ß-glucan enhances lipid-lowering effects of phytosterols. A randomised controlled trial', Clinical Nutrition, 39 80-89 (2020) [C1]
|
Nova | |||||||||
2019 |
Ferguson JJA, Wolska A, Remaley AT, Stojanovski E, MacDonald-Wicks L, Garg ML, 'Bread enriched with phytosterols with or without curcumin modulates lipoprotein profiles in hypercholesterolaemic individuals. A randomised controlled trial', FOOD & FUNCTION, 10 2515-2527 (2019) [C1]
|
Nova | |||||||||
2018 |
Thota RN, Ferguson JJA, Abbott KA, Dias CB, Garg ML, 'Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects vs. clinical outcomes', Food and Function, 9 3576-3596 (2018) [C1] Lower incidence of cardiovascular disease (CVD) in the Greenland Inuit, Northern Canada and Japan has been attributed to their consumption of seafood rich in long chain omega-3 po... [more] Lower incidence of cardiovascular disease (CVD) in the Greenland Inuit, Northern Canada and Japan has been attributed to their consumption of seafood rich in long chain omega-3 polyunsaturated fatty acids (LCn-3PUFA). While a large majority of pre-clinical and intervention trials have demonstrated heart health benefits of LCn-3PUFA, some studies have shown no effects or even negative effects. LCn-3PUFA have been shown to favourably modulate blood lipid levels, particularly a reduction in circulating levels of triglycerides. High density lipoprotein-cholesterol (HDL-C) levels are elevated following dietary supplementation with LCn-3PUFA. Although LCn-3PUFA have been shown to increase low-density lipoprotein-cholesterol (LDL-C) levels, the increase is primarily in the large-buoyant particles that are less atherogenic than small-dense LDL particles. The anti-inflammatory effects of LCn-3PUFA have been clearly outlined with inhibition of NFkB mediated cytokine production being the main mechanism. In addition, reduction in adhesion molecules (intercellular adhesion molecule, ICAM and vascular cell adhesion molecule 1, VCAM-1) and leukotriene production have also been demonstrated following LCn-3PUFA supplementation. Anti-aggregatory effects of LCn-3PUFA have been a subject of controversy, however, recent studies showing sex-specific effects on platelet aggregation have helped resolve the effects on hyperactive platelets. Improvements in endothelium function, blood flow and blood pressure after LCn-3PUFA supplementation add to the mechanistic explanation on their cardio-protective effects. Modulation of adipose tissue secretions including pro-inflammatory mediators and adipokines by LCn-3PUFA has re-ignited interest in their cardiovascular health benefits. The aim of this narrative review is to filter out the reasons for possible disparity between cohort, mechanistic, pre-clinical and clinical studies. The focus of the article is to provide possible explanation for the observed controversies surrounding heart health benefits of LCn-3PUFA.
|
Nova | |||||||||
2018 |
Ferguson JJA, Stojanovski E, MacDonald-Wicks L, Garg ML, 'Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial', Metabolism: Clinical and Experimental, 82 22-35 (2018) [C1]
|
Nova | |||||||||
2017 |
Thota RN, Abbott KA, Ferguson JJA, Veysey M, Lucock M, Niblett S, et al., 'InsuTAG: A novel physiologically relevant predictor for insulin resistance and metabolic syndrome.', Scientific reports, 7 15204 (2017) [C1]
|
Nova | |||||||||
2016 |
Ferguson JJA, Stojanovski E, MacDonald-Wicks L, Garg ML, 'Fat type in phytosterol products influence their cholesterol-lowering potential: A systematic review and meta-analysis of RCTs', Progress in Lipid Research, 64 16-29 (2016) [C1] The most common form of phytosterol (PS) fortified foods are fat spreads and dairy products. The predominant fats used are soybean/sunflower (SS) or rapeseed/canola (RC) oils and ... [more] The most common form of phytosterol (PS) fortified foods are fat spreads and dairy products. The predominant fats used are soybean/sunflower (SS) or rapeseed/canola (RC) oils and animal fat (D) in dairy products. This review aimed to investigate whether the carrier fat is a determinant of the hypocholesterolaemic effects of PS fortified foods. Databases were searched using relevant keywords and published RCTs from 1990 investigating the effects of dietary PS intervention (=¿1.5¿g per day) on total cholesterol and LDL-C were included. After methodological quality assessment and data extraction, a total of 32 RCTs (RC, n¿=¿15; SS, n¿=¿9; D, n¿=¿8) were included. As expected, all fat groups significantly reduced TC and LDL-C (p¿<¿0.01). When compared across different carrier fats, RC as the main carrier fat, reduced LDL-C significantly more than the SS spreads (p¿=¿0.01). Therefore, a combination of monounsaturated fatty acid rich spread with adequate amounts of omega-3 fatty acids (as evident in RC spreads) may be the superior carrier fat for the delivery of PS for optimal blood cholesterol-lowering. The findings of this research provide useful evidence for optimising the hypocholesterolaemic effects of PS and support further investigation into the possible mechanisms behind these findings.
|
Nova | |||||||||
2016 |
Ferguson JJA, Veysey M, Lucock M, Niblett S, King K, MacDonald-Wicks L, Garg ML, 'Association between omega-3 index and blood lipids in older Australians', Journal of Nutritional Biochemistry, 27 233-240 (2016) [C1] Management of hyperlipidaemia remains a cornerstone therapy for the prevention of cardiovascular disease (CVD). Dietary supplementation with n-3 polyunsaturated fatty acid (PUFA) ... [more] Management of hyperlipidaemia remains a cornerstone therapy for the prevention of cardiovascular disease (CVD). Dietary supplementation with n-3 polyunsaturated fatty acid (PUFA) has been shown to modulate blood lipid profiles and reduce the risk of developing CVD. However, studies relating objective measures of long-term dietary n-3 PUFA intake and circulating lipid levels in older adults are limited. Thus, we aimed to determine whether there is an association between erythrocyte n-3 PUFA status (omega-3 index, O3I) and blood lipid profiles in older adults. A sample of adults aged 65-95 years who participated in the Retirement Health and Lifestyle Study was evaluated. Outcome measures included O3I (% eicosapentaenoic acid+% docosahexaenoic acid) and fasting blood lipid profiles [total cholesterol (TC), low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol and triglyceride (TG)]. Two hundred and seventy-six subjects were included in the analyses. The mean±SD age was 77.6±7.4 years, and 40.9% were males. O3I was significantly higher in females compared to males. O3I was inversely associated with plasma TG (P<.001) and TC/HDL-cholesterol ratio (P<.05), and positively associated with HDL-cholesterol (P<.05), in all subjects. Associations between O3I and TG were evident in both females (r=-0.250, P<.01) and males (r=-0.225, P<.05). In females only, the odds of being hypertriglyceridaemic were highest in those with lowest O3I (P=006). Trends for hypercholesterolaemia and elevated LDL risk were converse between males and females. Long-term n-3 PUFA status is associated with blood lipid profiles in older Australians. Our findings support the development and implementation of age-specific dietary strategies to reduce the risk of CVD via improving the O3I.
|
Nova | |||||||||
Show 16 more journal articles |
Conference (3 outputs)
Year | Citation | Altmetrics | Link | |||||
---|---|---|---|---|---|---|---|---|
2023 |
Ferguson JJA, Austin G, Oldmeadow C, Garg ML, 'Plant-based dietary patterns and cardiovascular disease risk in Australians: the Plant-Based Diet Cohort study protocol', PROCEEDINGS OF THE NUTRITION SOCIETY (2023)
|
|||||||
2023 |
Ferguson JJA, Oldmeadow C, Bentley D, Garg ML, 'Antioxidant effects of a polyphenol-rich dietary supplement containing Pinus massoniana bark extract in healthy older adults: a two-arm, parallel group, randomized placebo-controlled trial', PROCEEDINGS OF THE NUTRITION SOCIETY (2023)
|
|||||||
2017 |
Ferguson JJA, Stojanovski E, MacDonald-Wicks L, Garg ML, 'Lipid-Lowering Potential of Combined Phytosterols and Curcumin Supplementation in Hypercholesterolaemic Individuals', FASEB JOURNAL, Chicago, IL (2017)
|
Grants and Funding
Summary
Number of grants | 11 |
---|---|
Total funding | $366,613 |
Click on a grant title below to expand the full details for that specific grant.
20221 grants / $14,086
HMRI Food and Nutrition Program Philanthropy Grant$14,086
Funding body: Hunter Medical Research Institute (HMRI)
Funding body | Hunter Medical Research Institute (HMRI) |
---|---|
Project Team | Dr Jessica Ferguson, Ms Grace Austin, Prof Manohar Garg |
Scheme | HMRI Food and Nutrition Program Philanthropy Grant |
Role | Lead |
Funding Start | 2022 |
Funding Finish | 2022 |
GNo | |
Type Of Funding | External |
Category | EXTE |
UON | N |
20214 grants / $74,818
HMRI Researcher Bridging Funds$52,238
Funding body: Hunter Medical Research Institute
Funding body | Hunter Medical Research Institute |
---|---|
Project Team | Doctor Jessica Ferguson, Prof MANOHAR Garg |
Scheme | Research Grant |
Role | Lead |
Funding Start | 2021 |
Funding Finish | 2021 |
GNo | G2100136 |
Type Of Funding | C3300 – Aust Philanthropy |
Category | 3300 |
UON | Y |
2021 College of Health, Medicine and Wellbeing Strategic Research Pilot Grant$14,100
Funding body: College of Health, Medicine and Wellbeing, University of Newcastle
Funding body | College of Health, Medicine and Wellbeing, University of Newcastle |
---|---|
Project Team | Dr Jessica Ferguson, Professor Manohar Garg |
Scheme | Strategic Research Pilot Grant |
Role | Lead |
Funding Start | 2021 |
Funding Finish | 2021 |
GNo | |
Type Of Funding | Internal |
Category | INTE |
UON | N |
Antioxidants for Active Ageing (Ageing Well Trial)$4,980
Funding body: Hunter Medical Research Institute
Funding body | Hunter Medical Research Institute |
---|---|
Project Team | Doctor Jessica Ferguson, Prof MANOHAR Garg |
Scheme | Research Grant |
Role | Lead |
Funding Start | 2021 |
Funding Finish | 2021 |
GNo | G2101041 |
Type Of Funding | C3300 – Aust Philanthropy |
Category | 3300 |
UON | Y |
PRCPAN EMCR Publication Scheme 2021$3,500
Funding body: PRC in Physical Activity and Nutrition, University of Newcastle
Funding body | PRC in Physical Activity and Nutrition, University of Newcastle |
---|---|
Scheme | PRCPAN EMCR Publication Scheme 2021 |
Role | Lead |
Funding Start | 2021 |
Funding Finish | 2021 |
GNo | |
Type Of Funding | Internal |
Category | INTE |
UON | N |
20202 grants / $196,030
RecoveR8: Optimizing healthy ageing and improving well-being$195,500
Funding body: Tismor Health and Wellness Pty Ltd
Funding body | Tismor Health and Wellness Pty Ltd |
---|---|
Project Team | Prof MANOHAR Garg, Doctor David Bentley, Doctor Jessica Ferguson |
Scheme | Research Grant |
Role | Investigator |
Funding Start | 2020 |
Funding Finish | 2021 |
GNo | G2000808 |
Type Of Funding | C3100 – Aust For Profit |
Category | 3100 |
UON | Y |
PRCPAN Research Booster Scheme$530
Funding body: PRC in Physical Activity and Nutrition, University of Newcastle
Funding body | PRC in Physical Activity and Nutrition, University of Newcastle |
---|---|
Scheme | 2020 PRCPAN Research Booster Scheme |
Role | Lead |
Funding Start | 2020 |
Funding Finish | 2020 |
GNo | |
Type Of Funding | Internal |
Category | INTE |
UON | N |
20181 grants / $5,000
Faculty of Health and Medicine Grant in Aid $5,000
Funding body: Faculty of Health and Medicine, University of Newcastle
Funding body | Faculty of Health and Medicine, University of Newcastle |
---|---|
Scheme | Faculty of Health and Medicine Grant in Aid |
Role | Lead |
Funding Start | 2018 |
Funding Finish | 2018 |
GNo | |
Type Of Funding | Internal |
Category | INTE |
UON | N |
20173 grants / $76,679
Complementary and/or synergistic effects of Phytosterols and Curcumin for reducing Cardiovascular Disease Risk in Hyperlipidaemic Individuals$61,679
Funding body: BASF (Asia Pacific)
Funding body | BASF (Asia Pacific) |
---|---|
Project Team | Professor Manohar Garg |
Scheme | Newtrition Asia Research Grant |
Role | Lead |
Funding Start | 2017 |
Funding Finish | 2018 |
GNo | |
Type Of Funding | C3211 - International For profit |
Category | 3211 |
UON | N |
Optimising lipid-lowering ability of dietary phytosterols for reducing cardiovascular disease risk$10,000
Funding body: Hunter Medical Research Institute (HMRI)
Funding body | Hunter Medical Research Institute (HMRI) |
---|---|
Project Team | Professor Manohar Garg, Associate Professor Lesley MacDonald-Wicks, Doctor Elizabeth Stojanovski |
Scheme | Greaves family postgraduate scholarship in medical research |
Role | Lead |
Funding Start | 2017 |
Funding Finish | 2017 |
GNo | |
Type Of Funding | C3120 - Aust Philanthropy |
Category | 3120 |
UON | N |
Optimising lipid-lowering ability of dietary phytosterols for reducing cardiovascular disease risk$5,000
Funding body: Hunter Medical Research Institute (HMRI)
Funding body | Hunter Medical Research Institute (HMRI) |
---|---|
Project Team | Professor Manohar Garg, Associate Professor Lesley MacDonald-Wicks, Doctor Elizabeth Stojanovski |
Scheme | HMRI Student Association 'Future' Postgraduate Medical Research Scholarship |
Role | Lead |
Funding Start | 2017 |
Funding Finish | 2017 |
GNo | |
Type Of Funding | C3120 - Aust Philanthropy |
Category | 3120 |
UON | N |
Research Supervision
Number of supervisions
Current Supervision
Commenced | Level of Study | Research Title | Program | Supervisor Type |
---|---|---|---|---|
2020 | PhD | Plant Based Diets for Reducing Cardiovascular Disease Risk | PhD (Nutritional Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle | Co-Supervisor |
Dr Jessica Ferguson
Position
Research Assistant
Nutraceuticals Research Program
School of Health Sciences
College of Health, Medicine and Wellbeing
Contact Details
jessica.ferguson@newcastle.edu.au | |
Phone | (02) 4921 5636 |
Office
Room | MS.305 |
---|---|
Building | Medical Sciences Building |
Location | Callaghan University Drive Callaghan, NSW 2308 Australia |